Pharma Foods International Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Pharma Foods International has a total shareholder equity of ¥11.6B and total debt of ¥16.9B, which brings its debt-to-equity ratio to 145.8%. Its total assets and total liabilities are ¥36.6B and ¥25.0B respectively. Pharma Foods International's EBIT is ¥5.1B making its interest coverage ratio 155. It has cash and short-term investments of ¥15.7B.
Anahtar bilgiler
145.8%
Borç/özkaynak oranı
JP¥16.89b
Borç
Faiz karşılama oranı | 155x |
Nakit | JP¥15.67b |
Eşitlik | JP¥11.59b |
Toplam yükümlülükler | JP¥24.99b |
Toplam varlıklar | JP¥36.57b |
Son finansal sağlık güncellemeleri
Recent updates
Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares
Oct 31We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated
Sep 22Is Pharma Foods International (TSE:2929) Using Too Much Debt?
Jul 23We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit
Mar 23Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 2929's short term assets (¥27.3B) exceed its short term liabilities (¥23.2B).
Uzun Vadeli Yükümlülükler: 2929's short term assets (¥27.3B) exceed its long term liabilities (¥1.8B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 2929's net debt to equity ratio (10.6%) is considered satisfactory.
Borcun Azaltılması: 2929's debt to equity ratio has increased from 72% to 145.8% over the past 5 years.
Borç Kapsamı: 2929's debt is well covered by operating cash flow (32.5%).
Faiz Kapsamı: 2929's interest payments on its debt are well covered by EBIT (155x coverage).